For the full year sales increased 4.0% to 23.7 billions, with a net profit of 9.57 billions. Total debt: 34.0 billions. The company product's innovation is very intense, currenty has 10 firt-in-human molecules in clinical development.
Current Downtrend, this could range for awhile. I do enjoy trading this ticker, ill consider taking short positions near top of downtrend line but I don't plan on taking long positions until the trend changes.
Like this gap down.. I'll wait for the first 5 min candle and play the break of that. Since this is a red candle gaping down it could retest then roll over.c Might take a few min to really break down or just head fake and go back up.
Here we have Amgen Stock chart. Bigger picture suggesting that there is more room to fall until we reach significant areas of demand. As we move to the lower time frame we can see fresh supply sitting above and very little demand below. Will look for an entry here.